Decreased adenosine receptor binding in dystonic brains of the dt sz mutant

Neuroscience

Volumn 134, Issue 1, 2005, Pages 33-38

  Nobrega, J N ^b   Barlow, K L ^b   Raymond, R ^b   Richter, A ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Adenosine receptors; Basal ganglia disorders; Dyskinesia; Dystonia; Movement disorders

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DYSTONIA; HAMSTER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; STRESS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; AUTORADIOGRAPHY; CRICETINAE; DISEASE MODELS, ANIMAL; DYSTONIC DISORDERS; PROTEIN BINDING; RECEPTORS, PURINERGIC P1; TRITIUM; XANTHINES;

EID: 21744446565     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2005.03.033     Document Type: Article

References (45)

1. S.M. Anderson, J.R. Leu, G.J. Kant Effects of stress on [3H]cyclohexyadenosine binding to rat brain membranes Pharmacol Biochem Behav 26 1987 829 833
2. sz mutants J Neurosci 21 2001 RC153
3. D. Blum, R. Hourez, M.C. Galas, P. Popoli, S.N. Schiffmann Adenosine receptors and Huntington's disease implications for pathogenesis and therapeutics Lancet Neurol 2 2003 366 374
4. J.P. Boulenger, P.J. Marangos, K.J. Zander, J. Hanson Stress and caffeine effects on central adenosine receptors Clin Neuropharmacol 9 1986 79 83
5. F. Calon, S. Birdi, A.H. Rajput, O. Hornykiewicz, P.J. Bedard, T. Di Paolo Increased of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias J Neuropathol Exp Neurol 61 2002 186 196
6. F. Calon, M. Dridi, O. Hornykiewicz, P.J. Bedard, A.H. Rajput, T. Di Paolo Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias Brain 127 2004 1075 1084
7. E.Y. Chan, R. Luthi-Carter, A. Strand, S.M. Solano, S.A. Hanson, M.M. DeJohn, C. Kooperberg, K.O. Chase, M. DiFiglia, A.B. Young, B.R. Leavitt, J.H. Cha, N. Aronin, M.R. Hayden, J.M. Olson Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease Hum Mol Genet 11 2002 1939 1951
8. 2A antagonist KW6002 from animal models to parkinsonian patients Neurology 61 2003 107 111
9. S. Fahn The paroxysmal dyskinesias C.D. Marsden S. Fahn Movement disorders 3 1994 Butterworth-Heinemann Oxford 311 345
10. S. Fahn, S.B. Bressman, C.D. Marsden Classification of dystonia Adv Neurol 78 1998 1 10
11. S. Ferré, W.T. O'Connor, P. Svenningsson, L. Björklund, J. Lindberg, B. Tinner, I. Strömberg, M. Goldstein, S. Ögren, U. Ungerstedt, B. Fredholm, K. Fuxe Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat striatoentopeduncular pathway and its modulation of adenosine A1 receptor-mediated mechanism Eur J Neurosci 8 1996 1545 1553
12. S. Ferré, B.B. Fredholm, M. Morelli, P. Popoli, K. Fuxe Adenosine-dopamine receptor interactions as an integrative mechanism in the basal ganglia Trends Neurosci 20 1997 482 487
13. S. Ferré, K. Fuxe, G. von Euler, B. Johannson, B.B. Fredholm Adenosine-dopamine interactions in the brain Neuroscience 51 1992 501 512
14. B.B. Fredholm Purinoceptors in the nervous system Pharmacol Toxicol 76 1995 228 239
15. B.B. Fredholm, M.P. Abbracchio, G. Burnstock, J.W. Daly, T.K. Harden, K.A. Jacobseb, P. Leff, M. Williams Nomenclature and classification of purinoceptors Pharmacol Rev 46 1994 143 156
16. K. Fuxe, S. Ferré, M. Zoli, L.F. Agnati Integrated events in central dopamine transmission as analysed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia Brain Res Rev 26 1998 258 273
17. M. Gernert, A. Richter, W. Löscher Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters Brain Res 821 1999 277 285
18. M. Gernert, M. Hamann, M. Bennay, W. Löscher, A. Richter Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia J Neurosci 20 2000 7052 7058
19. M. Glass, M. Dragunow, R.L. Faull The pattern of neurodegeneration in Huntington's disease a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease Neuroscience 97 2000 505 519
20. L. Halldner, U. Aden, V. Dqahlberg, B. Johansson, C. Ledent, B.B. Fredholm The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion a study in mice lacking adenosine A1 and/or A2A receptors Neuropharmacology 46 2004 1008 1017
21. M. Hamann, A. Richter Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia Neurobiol Dis 16 2004 78 84
22. M.F. Jarvis, M. Williams Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680 Eur J Pharmacol 168 1989 243 246
23. P. Jenner A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD Neurology 61 11 Suppl. 6 2003 S32 S38
24. T. Kanda, M.J. Jackson, L.A. Smith, R.K.B. Pearce, J. Nakamura, H. Kase, Y. Kuwana, P. Jenner Adenosine A2A antagonist A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys Ann Neurol 43 1998 507 513
25. C. Ledent, J.M. Vangeois, S.N. Schiffmann, T. Pedrazzini, M. El Yacoubi, J.J. Vanderhaeghen, J. Costentin, J.K. Heath, G. Vassart, M. Parmentier Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2A receptor Nature 388 1997 674 678
26. H. Matsuo, K. Kamakura, M. Saito, M. Okano, T. Nagase, Y. Tadano, K. Kaida, A. Hirata, N. Miyamoto, T. Masaki, R. Nakamura, K. Motoyoshi, H. Tanaka, S. Tsuji Familial paroxysmal dystonic choreoathetosis. Clinical findings in a large Japanese family and genetic linkage to 2q Arch Neurol 56 1999 721 726
27. L.P. Morin, R.I. Wood A stereotaxic atlas of the golden hamster brain 2001 Academic Press San Diego
28. N. Nardocci, E. Fernandez-Alvarez, N.W. Wood, S.D. Spacy, A. Richter The paroxysmal dyskinesias R. Guerrini J. Aicardi F. Andermann M. Hallett Epilepsy and movement disorders 2002 Cambridge University Press Cambridge 125 139
29. J.N. Nobrega, J.H. Parkes, P. Wong, R. Raymond, A. Richter Altered expression of preproenkephalin and prodynorphin mRNA in a genetic model of paroxysmal dystonia Brain Res 1015 2004 87 95
30. J.N. Nobrega, A. Richter, N. Tozman, D. Jiwa, W. Löscher Quantitative autoradiography reveals regionally selective changes in dopamine D1 and D2 receptor binding in the genetically dystonic hamster Neuroscience 71 1996 927 936
31. M. Okada, K. Kiryu, Y. Kawata, K. Mizuno, K. Wada, H. Tasaki, S. Kaneko Determination of the effects of caffeine and carbamazepine on striatal dopamine by in vivo microdialysis Eur J Pharmacol 321 1997 181 188
32. E. Ongini, B.B. Fredholm Pharmacology of adenosine A2A receptors Trends Pharmacol Sci 17 1996 364 372
33. A. Pinna, C. Corsi, A.R. Carta, V. Valentini, F. Pedata, M. Morelli Modification of adenosine extracellular levels and adenosine A2A receptor mRNA by dopamine denervation Eur J Pharmacol 446 2002 75 82
34. P. Popoli, A. Pezzola, R. Reggio, M.G. Caporali, A.S. de Carolis CGS 21680 antagonizes motor hyperactivity in a rat model of Huntington's disease Eur J Pharmacol 257 1994 R5 R6
35. 2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum J Neurosci 22 2002 1967 1975
36. J.H. Rehders, W. Löscher, A. Richter Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model Neuroscience 97 2000 267 277
37. A. Richter, K. Barlow, R. Raymond, M. Hamann, J.N. Nobrega Decreases in adenosine A1 receptor binding in an animal model of paroxysmal dyskinesia Mov Disord 19 suppl. 9 2004 S81 (P196)
38. A. Richter, J.M. Brotchie, A.R. Crossman, W. Löscher [3H]-2-Deoxyglucose uptake study in mutant dystonic hamsters Abnormalities in discrete brain regions of the motor system Mov Disord 13 1998 718 725
39. A. Richter, M. Hamann, C. Bartling CGS 21680 exerts marked antidystonic effects in a genetic model of paroxysmal dyskinesia Eur J Pharmacol 404 2000 299 302
40. A. Richter, M. Hamann Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary dystonia Br J Pharmacol 134 2001 343 352
41. A. Richter, W. Löscher Pathophysiology of idiopathic dystonia findings from genetic animal models Prog Neurobiol 54 1998 633 677
42. A. Richter, W. Löscher Animal models of paroxysmal dystonia Adv Neurol 89 2002 443 451
43. A.M. Sebastiao, J.A. Ribeiro Fine-tuning neuromodulation by adenosine Trends Pharmacol Sci 21 2000 341 346
44. 2A receptors in rat brain J Pharmacol Exp Ther 280 1997 1094 1101
45. R.D. Todd, J.S. Perlmutter Mutational and biochemical analysis of dopamine in dystonia Mol Neurobiol 16 1998 135 147